Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Caturkarda Depo Bangunan Tbk. (DEPO) vs UBC Medical Indonesia Tbk. (LABS) Price & Performance

Caturkarda Depo Bangunan Tbk.Trade
UBC Medical Indonesia Tbk.Trade

Price performance (Past 24H)

Key statistics

Caturkarda Depo Bangunan Tbk. vs UBC Medical Indonesia Tbk. — how do they compare? Caturkarda Depo Bangunan Tbk. trades at Rp244 (market cap 1.68T, 535.1K 24h volume), while UBC Medical Indonesia Tbk. trades at Rp167 (market cap 651.75B, 626.9K 24h volume). The key difference: Caturkarda Depo Bangunan Tbk. is far larger — about 2.6× UBC Medical Indonesia Tbk.'s market cap, and UBC Medical Indonesia Tbk. is more actively traded (626.9K versus 535.1K). Which is the better fit depends on your goals.

DEPOLABS
Market Cap
1.68T651.75B
Volume
535.1K626.9K
Lot
5.35K6.27K
Turnover
131.61M103.6M
Average Price
245.95165.25
Value
131.61M103.6M
Indicative Equilibrium Price
250165
Indicative Equilibrium Volume
4300

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

DEPO
View details
LABS
View details

About Caturkarda Depo Bangunan Tbk.

PT Caturkarda Depo Bangunan Tbk (the “Company”) was established based on Notarial Deed No. 5 dated January 3, 1996 of Public Notary Mrs. Poerbaningsih Adi Warsito, S.H., a Notary in Jakarta. The Company commenced its commercial operations in 1996.

Read more on DEPO

About UBC Medical Indonesia Tbk.

PT UBC Medical Indonesia (the Company) was established under the framework of Law of the Republic of Indonesia No. 20 year 1994 concerning the Foreign Capital Investment, as amended by Law No. 25 year 2007 concerning the Capital Investment based on Notarial Deed No. 01 dated 4 June 2014 of Novita Puspitarini, S.H., Notary in Jakarta. The Company started its commercial activities in October 2014. The parent entity as well as the ultimate parent entity of the Company is PT Optel Investama Mulia.

Read more on LABS